22 September 2026
Herbert Smith Freehills Kramer advises Telix Pharmaceuticals Limited on its transformational merger with ITM Isotope Technologies Munich SE
Advising firms
Deal team
3 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Tim McEwen Lead | Herbert Smith Freehills Kramer | Partner | Not stated | Not stated |
| Jennifer Wong | Herbert Smith Freehills Kramer | Senior associate | Not stated | Not stated |
| Sarah Leong | Herbert Smith Freehills Kramer | Other | Not stated | Not stated |
Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 1.65bn (US$1.65 billion)
- What the figure measures
- Total transaction value
- Client
- Telix Pharmaceuticals LimitedBuy-side
- Counterparties
- ITM Isotope Technologies Munich SE (Sell-side)